Sanofi SA (EPA:SAN) received a €96.00 ($101.05) price target from stock analysts at Deutsche Bank AG in a research report issued on Wednesday. The brokerage currently has a “buy” rating on the stock.

Other equities research analysts also recently issued reports about the stock. Kepler Capital Markets set a €89.00 ($93.68) price target on shares of Sanofi SA and gave the company a “buy” rating in a research note on Thursday, August 11th. Morgan Stanley set a €91.00 ($95.79) price target on shares of Sanofi SA and gave the company a “buy” rating in a research note on Tuesday. JPMorgan Chase & Co. set a €71.00 ($74.74) price target on shares of Sanofi SA and gave the company a “sell” rating in a research note on Thursday, September 15th. Jefferies Group set a €76.00 ($80.00) price target on shares of Sanofi SA and gave the company a “neutral” rating in a research note on Tuesday, September 13th. Finally, Berenberg Bank set a €93.00 ($97.89) price target on shares of Sanofi SA and gave the company a “buy” rating in a research note on Thursday, September 8th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of €84.07 ($88.49).

Analyst Recommendations for Sanofi SA (EPA:SAN)

Shares of Sanofi SA (EPA:SAN) opened at 76.82 on Wednesday. Sanofi SA has a 52 week low of €62.50 and a 52 week high of €84.81. The firm has a market capitalization of €98.87 billion and a P/E ratio of 23.57. The firm has a 50-day moving average of €25.50 and a 200 day moving average of €25.74.

COPYRIGHT VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and republished in violation of U.S. & international copyright laws. The correct version of this report can be accessed at https://www.thecerbatgem.com/2016/11/30/deutsche-bank-ag-analysts-give-sanofi-sa-san-a-96-00-price-target.html.

Sanofi SA Company Profile

Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.

Receive News & Stock Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related stocks with our FREE daily email newsletter.